How would you define the success of Verily's Project Baseline Health Study?

Introduction

Defining the success of Verily's Project Baseline Health Study requires a comprehensive approach that considers multiple stakeholders and long-term impact. To address this product success metrics challenge, I'll follow a structured framework covering core metrics, supporting indicators, and risk factors while considering all key stakeholders.

Step 1

Product Context

Project Baseline Health Study is a longitudinal health study initiated by Verily, Alphabet's life sciences arm. The study aims to collect comprehensive health data from a diverse group of participants over several years to create a baseline of human health and identify early warning signs of diseases.

Key stakeholders include:

1. Participants: Motivated by understanding their health and contributing to scientific research
2. Researchers: Seeking high-quality, longitudinal health data
3. Healthcare providers: Interested in insights that could improve patient care
4. Verily/Alphabet: Aiming to establish a leadership position in health data and analytics

User flow:

1. Recruitment: Participants are screened and enrolled
2. Initial assessment: Comprehensive health examination and data collection
3. Ongoing monitoring: Regular check-ins, wearable device data collection, and periodic assessments
4. Data analysis: Researchers analyze aggregated, anonymized data

The study fits into Alphabet's broader strategy of leveraging data and technology to revolutionize healthcare. It positions Verily as a leader in health data collection and analysis, potentially informing future product development and partnerships.

Competitors like Apple Health Studies and All of Us Research Program also conduct large-scale health studies, but Project Baseline's comprehensive approach and Alphabet's data expertise set it apart.

Product Lifecycle Stage: Growth phase. The study has moved beyond initial launch and is actively expanding its participant base and data collection efforts.